Literature DB >> 3233804

Quantitation of myocardial fibrosis and its relation to function in essential hypertension and hypertrophic cardiomyopathy.

N Sugihara1, A Genda, M Shimizu, T Suematu, Y Kita, Y Horita, R Takeda.   

Abstract

Myocardial interstitial fibrosis is an important microscopic feature of hypertrophic cardiomyopathy. To determine whether interstitial fibrosis of the myocardium in hypertrophic cardiomyopathy and essential hypertension differ in quality or quantity, and to determine whether fibrosis affects cardiac function directly, we measured the percentage of fibrosis in patients of both categories and compared the severity of fibrosis with several cardiac functions. Left and right ventricular endomyocardial biopsies were performed in 25 patients with essential hypertension and in 19 patients with hypertrophic cardiomyopathy. Interstitial fibrosis was classified into four different microscopic types, and the percentage of total and of each type was calculated using the point-counting method. Although the percentage of total fibrosis was similar between the two groups, the type of fibrosis was different. There was no correlation between the percentage of total fibrosis and the mean size of myocytes in either group. Although there was a significant correlation between the percentage of total fibrosis and the thickness of the interventricular septum in hypertrophic cardiomyopathy, such correlation was lacking in hypertension. There was no correlation between the percentage of total fibrosis and the ejection fraction, cardiac index, or left ventricular end-diastolic pressure in either group. We concluded that the amount of myocardial interstitial fibrosis in hypertrophic cardiomyopathy is no greater than that in essential hypertension, but the type of fibrosis is different. Furthermore, in subjects in whom the ejection fraction is normal or only slightly decreased, fibrosis does not influence global cardiac functions.

Entities:  

Mesh:

Year:  1988        PMID: 3233804     DOI: 10.1002/clc.4960111109

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

Review 1.  Transient receptor potential (TRP) channels and cardiac fibrosis.

Authors:  Zhichao Yue; Yanhui Zhang; Jia Xie; Jianmin Jiang; Lixia Yue
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

2.  Atrophic cardiomyocyte signaling in hypertensive heart disease.

Authors:  German Kamalov; Wenyuan Zhao; Tieqiang Zhao; Yao Sun; Robert A Ahokas; Tony N Marion; Fahed Al Darazi; Ivan C Gerling; Syamal K Bhattacharya; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2013-12       Impact factor: 3.105

3.  Collagen remodelling in myocardia of patients with diabetes.

Authors:  M Shimizu; K Umeda; N Sugihara; H Yoshio; H Ino; R Takeda; Y Okada; I Nakanishi
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

4.  Measuring Water Distribution in the Heart: Preventing Edema Reduces Ischemia-Reperfusion Injury.

Authors:  Mireia Andrés-Villarreal; Ignasi Barba; Marcos Poncelas; Javier Inserte; José Rodriguez-Palomares; Victor Pineda; David Garcia-Dorado
Journal:  J Am Heart Assoc       Date:  2016-12-17       Impact factor: 5.501

Review 5.  Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy.

Authors:  Fuyu Zhu; Peng Li; Yanhui Sheng
Journal:  Front Pharmacol       Date:  2022-09-30       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.